SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pappy who wrote (395)1/30/1998 8:49:00 AM
From: Charlie Smith  Read Replies (1) of 1754
 
pappy:

<<The Company anticipates that procedures performed in the fourth quarter using VISX Systems will exceed its earlier expectations. Nevertheless, increased procedures by VISX users would not be sufficient to offset an expected shortfall in revenues from Pillar Point.>>

Nothing sinister here, in my opinion. They reserved for a portion of the PP revs. in the quarter as advised by their outside consultant, and they may have to take further reserves in the future. Royalties were stronger than expected, allowing them to overcome weak machine sales (as expected) and a portion of the shortfall in PP revenues.

Charlie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext